PB2351: ANXIETY AT THE HEMATOLOGIST

PB2351: ANXIETY AT THE HEMATOLOGIST

Bibliographic Details
Main Authors:	S. Trojan, A. Garma, V. Gveric-Krecak, I. Krecak
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000852228.53879.b9

Similar Items

PB2350: SAFETY AND EFFICACY OF HYPODERMOCLYSIS IN PATIENTS WITH HEMATOLOGICAL CANCERS
by: A. Kodru, et al.
Published: (2022-06-01)

Refractory Guillain-Barré Syndrome in a Patient with Asymptomatic Multiple Myeloma Successfully Treated with Low-Dose Rituximab
by: Ivan Krečak, et al.
Published: (2023-01-01)

PB1825: TREATMENT PATTERNS AND SURVIVAL OUTCOMES OF ACUTE MYELOID LEUKEMIA PATIENTS MANAGED IN THE COMMUNITY SETTING IN CROATIA
by: I. Krecak, et al.
Published: (2022-06-01)

PB2054: HIP AND KNEE OSTEOARTHRITIS IN PHILADELPHIA CHROMOSOME-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
by: H. Holik, et al.
Published: (2022-06-01)

Identification and evaluation of the novel immunodominant antigen Rv2351c from Mycobacterium tuberculosis
by: Xuezhi Wang, et al.
Published: (2017-01-01)

2351 Environmental barriers and facilitators of health care access and utilization for elderly stroke survivors
by: Allison Brenner, et al.
Published: (2018-06-01)

Gaucher Disease for Hematologists
by: Gül Nihal Özdemir, et al.
Published: (2022-05-01)

Make more pediatricians to hematologists and more hematologists to pediatricians, a dream come true
by: Mirta Caridad Campo Díaz.
Published: (2017-06-01)

III Congress of hematologists of Russia
by: Editorial article
Published: (2016-08-01)

PB2219: POLYPHARMACY AND DRUG-TO-DRUG INTERACTIONS MAY HAVE A NEGATIVE EFFECT ON SURVIVAL IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS
by: Ivan Krecak, et al.
Published: (2023-08-01)

Duffy‐null erythrocyte phenotype and the risk of thrombotic events in essential thrombocythemia
by: Ivan Krecak, et al.
Published: (2023-11-01)

PB2351: TRIAL IN PROGRESS: A PHASE 2, MULTICENTRE STUDY OF BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN FRONTLINE TREATMENT OF CHINESE PATIENTS WITH CD30-POSITIVE PERIPHERAL T-CELL LYMPHOMAS
by: Yuqin Song, et al.
Published: (2023-08-01)

PB2705: PROFESSIONAL BURNOUT AMONG HEMATOLOGISTS AFTER THE OUTBREAK OF THE COVID-19 PANDEMIC AND ASSOCIATED FACTORS
by: Olga Aleshina (Gavrilina), et al.
Published: (2023-08-01)

Chronic myeloid leukemia : a handbook for oncologists and hematologists /
by: Mughal, Tariq I., author
Published: (2013)

Acquired von Willebrand syndrome: focused for hematologists
by: Massimo Franchini, et al.
Published: (2020-08-01)

Cancer associated thrombosis: Which lessons for the hematologist?
by: Simon Noble
Published: (2018-06-01)

Acute Mesenteric Thrombosis: A Hematologist Perspective
by: Bushra Moiz, et al.
Published: (2020-06-01)

PB2201: ASSOCIATION OF HIGH PLATELETCRIT WITH THROMBOTIC RISK IN POLYCYTHEMIA VERA DEPENDS ON HEMATOCRIT AND LEUKOCYTE COUNT
by: Ivan Krecak, et al.
Published: (2023-08-01)

Should clinical hematologists put their microscopes on eBay?
by: Mars van’t Veer, et al.
Published: (2014-10-01)

Final diagnosis of patients referred to hematologist due to anemia
by: Nurhilal Buyukkurt, et al.
Published: (2020-03-01)

Cancer-associated thrombosis (CAT) - New challenges for the hematologist
by: Sigrid Brækkan
Published: (2018-06-01)

A survey of hematologists on compulsory health service in Turkey
by: Zeynep Arzu Yegin, et al.
Published: (2011-12-01)

A survey of hematologists on compulsory health service in Turkey
by: Zeynep Arzu Yeğin, et al.
Published: (2011-12-01)

Universal iron fortification of foods: the view of a hematologist
by: José Murilo Martins
Published: (2012-01-01)

Bortezomib Prescription Pattern for the Treatment of Multiple Myeloma by Hematologists in Nigeria
by: Kaladada I. Korubo, et al.
Published: (2017-10-01)

PB2188: PROTON PUMP INHIBITORS ARE SAFE AND EFFECTIVE IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA TREATED WITH LOW-DOSE ASPIRIN
by: Ivan Krecak, et al.
Published: (2023-08-01)

Abnormal uterine bleeding. Hemostatic therapy: hematologist point of view
by: Maria A. Vinogradova
Published: (2022-04-01)

Immune targeting of the microenvironment in classical Hodgkin’s lymphoma: insights for the hematologist
by: Nicole A. Carreau, et al.
Published: (2019-05-01)

INFECTIOUS DISEASES IN HEMATOLOGIST’S PRACTICE: VISCERAL LEYSHMANIASIS IN HIV-INFECTED PATIENT
by: Yu. N. Obgolts, et al.
Published: (2019-03-01)

Iron-deficiency anemia: a view of hematologist and gynecologist. Optimizing diagnostic and treatment approach
by: E.A. Lukina, et al.
Published: (2020-12-01)

Comment on: ‘Should clinical hematologists put their microscopes on eBay?’
by: Shaun R. McCann
Published: (2015-01-01)

Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist’s perspective
by: Athena Kritharis, et al.
Published: (2018-09-01)

Francesco Lo Coco, a distinguished hematologist and a friend
by: On behalf of the SIE, SIES and GIMEMA:, et al.
Published: (2019-04-01)

Fluctuating neurological symptoms: should I call the neurologist or the hematologist?
by: Losa-Rodríguez Rita, et al.
Published: (2020-11-01)

Knowledge, Attitudes, and Practices of Hematologists Regarding Fertility Preservation in Turkey
by: Mert Küçük, et al.
Published: (2013-09-01)

Hematologists' adaptations and contingency plans to the coronavirus disease-2019 crisis
by: Riad El Fakih
Published: (2020-01-01)

PB2269: HUMORAL AND T-CELL RESPONSES TO SARS-COV2 VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA MANAGED IN THE COMMUNITY SETTING
by: H. Holik, et al.
Published: (2022-06-01)

Corrigendum to "Estimates of biomass burning emissions in tropical Asia based on satellite-derived data" published in Atmos. Chem. Phys., 10, 2335–2351, 2010
by: D. Chang, et al.
Published: (2010-03-01)

Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms
by: Ivan Krečak, et al.
Published: (2023-04-01)

PB1943: THE EFFECTS OF AN ONLINE CURRICULUM BASED APPROACH TO CME ON HEMATOLOGIST/ONCOLOGISTS’ ABILITY TO TREAT PATIENTS WITH BTK INHIBITORS FOR B-CELL MALIGNANCIES
by: Sarah Elizabeth Bomba, et al.
Published: (2023-08-01)